,
your personalized virtual assistant to find clinical trials. Go head, 
Tammy Kindwall-Keller, D.O.
Case Comprehensive Cancer Center - ...Cleveland, Ohio - 44106 (216-844-5470) |
- CLINICAL TRIALS 2
- CONDITIONS3
- INTERVENTIONS6
- SINCE2010
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
July 2010 - December 2012
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
February 2010 - February 2013
Breast Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Filgrastim
Cisplatin
Bortezomib
Doxorubicin
Bendamustine
Pf-01367338
